薬剤耐性側頭葉症の背景における外科的および非外科的治療による側頭葉症のアウトカム:単一センター症例シリーズ
Anca-Mihaela Vasilica1, Jasneet Kaur Dhaliwal1, Debayan Dasgupta2
1University College London (UCL), Medical School, London, United Kingdom.
Epilepsy research
|August 29, 2025
まとめ
薬剤耐性エピレプシーにおける臨時脳梗塞の外科的管理は高い発作自由率を提供します. 標準化された評価と多学科チーム (MDT) の決定は,これらの患者に最適な外科的結果をもたらすために不可欠です.
科学分野:
- 神経外科
- エピレプトロジー
- 放射線科
背景:
- テンポラル・エンセファロケーレスは,薬剤耐性テンポラル・ロブ・エピレプシー (TLE) の既知の原因である.
- TLEにおける一時性脳硬化症の最適な管理戦略については,まだ議論が続いています.
- エピレプトゲネシスと外科の結果との関連を理解することは極めて重要です.
研究 の 目的:
- 臨時脳卒中患者の外科的および非外科的治療の結果を評価する.
- 発作の発生率と術後の合併症を比較する
- 薬剤耐性TLEの管理決定に影響を与える要因を特定する.
主な方法:
- テンポラル脳髄膜症の成人の単一センター研究 (2017年3月 - 2023年8月)
- MDTの議論に基づいた手術,非手術,放射線診断のグループに分類する.
- クリニカル,電気生理学,放射線学,外科学的データの比較,頭蓋内圧上昇 (ICP) マーカーを含む.
主要な成果:
- 8 患者は外科的,8 患者は非外科的,8 患者は放射線診断を受けた
- 手術グループ (側頭葉切除) では,発作の発生率は87. 5%でした.
- 非外科的または放射線診断のグループでは発作が起こらない (0%).
- 手術後の合併症には水頭症と 擬人眼球症が含まれていた.
結論:
- 側頭葉切除は 側頭葉髄膜症の薬剤耐性TLEで 優れた結果をもたらします
- 標準化された手術前評価と MDT プロトコルは最適な手術計画と結果のために不可欠です.
- 手術後のCSFの水力学的障害があるため,個別的な評価が不可欠です.
さらに関連する動画
関連する概念動画
Epilepsy and Seizures: Overview
1.7K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
Antiepileptic Drugs: Sodium Channel Blockers
2.4K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
2.4K
Antiepileptic Drugs: Glutamate Antagonists
1.3K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.3K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
1.2K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.2K
Electroconvulsive Therapy
2.2K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
2.2K
Psychosurgery
2.3K
Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
2.3K


